CM336 / Keymed Biosciences 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CM336 / Keymed Biosciences
NCT05299424: A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma

Not yet recruiting
1/2
48
NA
CM336_group 1, CM336_group 2a, CM336_group 2b, CM336_group 3a, CM336_group 3b, CM336_group 4a, CM336_group 4b, CM336_group 5, CM336_group 6a, CM336_group 6b, CM336_group 7, CM336_group 8a, CM336_group 8b, CM336_group 9, CM336_RP2D
Keymed Biosciences Co.Ltd
Multiple Myeloma
12/26
12/26

Download Options